Thomas DeLauer interviews physician Dr John Chef on what he sees as distortions in the “longevity” industry, arguing that social-media incentives push audiences towards single, simplified metrics rather than workable health strategies. Chef criticises what he describes as obsessive focus on surrogate markers such as grip strength and VO2 max, calling claims that VO2 max is the “most powerful” predictor of longevity “absurdly false”, and repeatedly centres muscle mass and metabolic health as the practical priority.
He argues that biomarker tracking can be useful only when it drives action, recommending sleep “awareness”, short-term continuous glucose monitoring paired with food journalling, and basic strength progression over chasing wearable-derived scores like HRV. He also broadens the discussion into evidence culture, claiming that a third of randomised controlled trials are never reproduced and citing the Women’s Health Initiative as a case where he says misinterpretation shaped care for decades.
Later, Chef endorses hormone optimisation as a tool for ageing adults trying to build muscle, while emphasising fundamentals such as sleep hygiene and training adherence. He describes the peptides marketplace as a “wild west”, alleging an MLM-like sales culture and saying consumers are misled by influencer stacks and, in some cases, physicians leveraging their authority to market products. Chef also discloses a genetically high lipoprotein(a) level and argues that cardiovascular disease should be more preventable given current knowledge, if care were better synthesised and coordinated.
Dr John Chef argues some doctors overstate VO2 max as the single strongest predictor of longevity. He says it is only one part of health and urges more attention to muscle health, recovery and metabolic markers than to one-number targets.
Read this moment →Dr John Chef says someone in their 50s could consider testosterone and a peptide “stack” to help build muscle. He argues hormone optimisation supports longevity via muscle and metabolic health, and says baseline biomarkers should guide any pharmacological support alongside training.
Read this moment →Dr John Chef says his lipoprotein(a) level is above 250, describing it as an inherited risk marker linked to heart attack and death. He argues that cardiovascular disease should not remain the leading cause of death, blaming fragmented, single-metric prevention approaches.
Read this moment →